The ‘grass ceiling’: limitations in the literature hinder our understanding of cannabis use and its consequences
Elizabeth C. Temple,
Rhonda F. Brown,
Donald W. Hine,
Corresponding Author
Elizabeth C. Temple
School of Behavioural and Social Sciences and Humanities, University of Ballarat, Ballarat, VIC
Elizabeth C. Temple, School of Behavioural and Social Sciences and Humanities, University of Ballarat, PO Box 663, Ballarat VIC 3353, Australia. E-mail: [email protected]Search for more papers by this authorRhonda F. Brown
School of Behavioural, Cognitive and Social Sciences, University of New England, Armidale, NSW, Australia
Search for more papers by this authorDonald W. Hine
School of Behavioural, Cognitive and Social Sciences, University of New England, Armidale, NSW, Australia
Search for more papers by this authorElizabeth C. Temple,
Rhonda F. Brown,
Donald W. Hine,
Corresponding Author
Elizabeth C. Temple
School of Behavioural and Social Sciences and Humanities, University of Ballarat, Ballarat, VIC
Elizabeth C. Temple, School of Behavioural and Social Sciences and Humanities, University of Ballarat, PO Box 663, Ballarat VIC 3353, Australia. E-mail: [email protected]Search for more papers by this authorRhonda F. Brown
School of Behavioural, Cognitive and Social Sciences, University of New England, Armidale, NSW, Australia
Search for more papers by this authorDonald W. Hine
School of Behavioural, Cognitive and Social Sciences, University of New England, Armidale, NSW, Australia
Search for more papers by this authorABSTRACT
Aim To illustrate how limitations in the cannabis literature undermine our ability to understand cannabis-related harms and problems experienced by users and identify users at increased risk of experiencing adverse outcomes of use.
Method and results Limitations have been organized into three overarching themes. The first relates to the classification systems employed by researchers to categorize cannabis users, their cannabis use and the assumptions on which these systems are based. The second theme encompasses methodological and reporting issues, including differences between studies, inadequate statistical control of potential confounders, the under-reporting of effect sizes and the lack of consideration of clinical significance. The final theme covers differing approaches to studying cannabis use, including recruitment methods. Limitations related to the nature of the data collected by researchers are discussed throughout, with a focus on how they affect our understanding of cannabis use and users.
Conclusions These limitations must be addressed to facilitate the development of effective and appropriately targeted evidence-based public health campaigns, treatment programmes and preventative, early intervention and harm minimization strategies, and to inform cannabis-related policy and legislation.
References
- 1 Egan D., Miron J. A. The budgetary implications of marijuana prohibition. In: M. Earleywine, editor. Pot Politics: Marijuana and the Costs of Prohibition. New York: Oxford University Press; 2007, p. 17–39.
- 2 United Nations Office on Drugs and Crime. World Drug Report 2009. New York: United Nations; 2009.
- 3 Room R., Fischer B., Hall W., Lenton S., Reuter P. The Global Cannabis Commission Report: Cannabis Policy—Moving Beyond Stalemate. Oxford: The Beckley Foundation; 2008.
- 4 Earleywine M. Understanding Marijuana Use: A New Look at the Scientific Evidence. New York: Oxford University Press; 2002.
- 5 Iversen L. L. The Science of Marijuana. New York: Oxford University Press; 2000.
- 6 Fischer B., Rehm J., Hall W. Cannabis use in Canada: the need for a ‘Public Health’ approach. Can J Public Health 2009; 100: 101–3.
- 7 Kisely S. The case for policy reform in cannabis control. Can J Psychiatry 2008; 53: 795–7.
- 8 Hall W., Room R. Should we recriminalize cannabis use? The case against. Can J Psychiatry 2008; 53: 793–4.
- 9 Macleod J., Oakes R., Copello A., Crome I., Egger M., Hickman M. et al. Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies. Lancet 2004; 363: 1579–88.
- 10 Nutt D. Estimating Drug Harms: A Risky Business? Briefing number: 10. London: Centre for Crime and Justice Studies; 2009.
- 11 Hall W., Lynskey M. The challenges in developing a rational cannabis policy. Curr Opin Psychiatry 2009; 22: 258–62.
- 12 World Health Organization (WHO). The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. Geneva: WHO; 1993.
- 13 APA. Diagnostic and Statistical Manual of Mental Disorders, 4th text revision. Washington, DC: American Psychiatric Association; 2000.
- 14 Swift W., Hall W., Teesson M. Characteristics of DSM-IV and ICD-10 cannabis dependence among Australian adults: results from the national survey of mental health and wellbeing. Drug Alcohol Depend 2001; 63: 147–53.
- 15 Swift W., Hall W., Didcott P., Reilly D. Patterns and correlates of cannabis dependence among long-term users in an Australian rural area. Addiction 1998; 93: 1149–60.
- 16 Alexander D. A marijuana screening inventory (experimental version): description and preliminary psychometric properties. Am J Drug Alcohol Abuse 2006; 29: 619–46.
- 17 Swift W., Hall W., Copeland J. Characteristics of long-term cannabis users in Sydney, Australia. Eur Addict Res 1998; 4: 190–7.
- 18 Dunlap E., Benoit E., Sifaneck S. J., Johnson B. D. Social constructions of dependency by blunt smokers: qualitative reports. Int J Drug Policy 2006; 17: 171–82.
- 19 Degenhardt L., Lynskey M., Coffey C., Patton G. ‘Diagnostic orphans’ among young adult cannabis users: person's who report dependence symptoms but do not meet diagnostic criteria. Drug Alcohol Depend 2002; 67: 205–12.
- 20 Chen K., Kandel D. B., Davies M. Relationships between frequency and quantity of marijuana use and last year proxy dependence among adolescents and adults in the United States. Drug Alcohol Depend 1997; 46: 53–67.
- 21 Chen C.-Y., Anthony J. C. Possible age-associated bias in reporting of clinical features of drug dependence: epidemiological evidence on adolescent-onset marijuana use. Addiction 2003; 98: 71–82.
- 22 Degenhardt L., Hall W., Lynskey M. Alcohol, cannabis and tobacco use among Australians: a comparison of their associations with other drug use and use disorders, affective and anxiety disorders, and psychosis. Addiction 2001; 96: 1603–14.
- 23 Fried P. A., Watkinson B., James D., Gray R. Current and former marijuana use: preliminary findings of a longitudinal study of effects on IQ in young adults. Can Med Assoc J 2002; 166: 887–91.
- 24 Rey J. M., Sawyer M. G., Raphael B., Patton G. C., Lynskey M. Mental health of teenagers who use cannabis. Results of an Australian survey. Br J Psychiatry 2002; 180: 216–21.
- 25 Patton G. C., Coffey C., Carlin J. B., Degenhardt L., Lynskey M., Hall W. Cannabis use and mental health in young people: cohort study. BMJ 2002; 325: 1195–8.
- 26 Ashton H. Pharmacology and effects of cannabis: a brief review. Br J Psychiatry 2001; 178: 101–6.
- 27 Looby A., Earleywine M. Negative consequences associated with dependence in daily cannabis users. Subst Abuse Treat Prev Policy 2007; 2: 3.
- 28 Hammersley R., Leon V. Patterns of cannabis use and positive and negative experiences of use amongst university students. Addict Res Theory 2006; 14: 189–205.
- 29 Miller P., Plant M. Heavy cannabis use among UK teenagers: an exploration. Drug Alcohol Depend 2002; 65: 235–42.
- 30 Block R. I., Erwin W. J., Farinpour R., Braverman K. Sedative, stimulant, and other subjective effects of marijuana: relationships to smoking techniques. Pharmacol Biochem Behav 1998; 59: 405–12.
- 31 Chabrol H., Roura C., Armitage J. Bongs, a method of using cannabis linked to dependence. Can J Psychiatry 2003; 48: 709.
- 32 Green B., Kavanagh D., Young R. Being stoned: a review of self-reported cannabis effects. Drug Alcohol Rev 2003; 22: 453–60.
- 33 Brodbeck J., Matter M., Page J., Moggi F. Motives for cannabis use as a moderator variable of distress among young adults. Addict Behav 2007; 32: 1537–45.
- 34 Moore T. H. M., Zammit S., Lingford-Hughes A., Barnes T. R. E., Jones P. B., Burke M. et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007; 370: 319–28.
- 35 Degenhardt L., Hall W., Lynskey M. Exploring the association between cannabis use and depression. Addiction 2003; 98: 1493–504.
- 36 Solowij N., Stephens R. S., Roffman R. A., Babor T., Kadden R., Miller M. et al. Cognitive functioning of long-term heavy cannabis users seeking treatment. JAMA 2002; 287: 1123–31.
- 37 Gonzalez R., Carey C., Grant I. Nonacute (residual) neuropsychological effects of cannabis use: a qualitative analysis and systematic review. J Clin Pharmacol 2002; 42: 48S–57S.
- 38 Kraus M. S., Keefe R. S. E. Cognition as an outcome measure in schizophrenia. Br J Psychiatry 2007; 191: S46–S51.
- 39 Spitznagel M. B., Suhr J. A. Neuropsychological impairment associated with symptoms of schizotypy: role of depressive and paranoid symptoms. J Nerv Ment Dis 2004; 192: 382–4.
- 40 Bolla K. I., Brown K., Eldreth D., Tate K., Cadet J. L. Dose-related neurocognitive effects of marijuana use. Neurology 2002; 59: 1337–43.
- 41 Duncan D. F., White J. B., Nicholson T. Using internet-based surveys to reach hidden populations: case of nonabusive illicit drug users. Am J Health Behav 2003; 27: 208–18.
- 42 Denson T. F., Earleywine M. Decreased depression in marijuana users. Addict Behav 2006; 31: 738–42.
- 43 Parker H. Normalization as a barometer: recreational drug use and the consumption of leisure by younger Britons. Addict Res Theory 2005; 13: 205–15.
- 44 Teesson M., Hall W., Lynskey M., Degenhardt L. Alcohol- and drug-use disorders in Australia: implications of the National Survey of Mental Health and Wellbeing. Aust NZ J Psychiatry 2000; 34: 206–13.
- 45 Coffey C., Carlin J. B., Lynskey M., Li N., Patton G. C. Adolescent precursors of cannabis dependence: findings from the Victorian Adolescent Health Cohort Study. Br J Psychiatry Suppl 2002; 182: 330–6.
- 46 McGee R., Williams S., Poulton R., Moffitt T. A longitudinal study of cannabis use and mental health from adolescence to early adulthood. Addiction 2000; 95: 491–503.
- 47 Fergusson D. M., Horwood L. J., Swain-Campbell N. Cannabis use and psychosocial adjustment in adolescence and young adulthood. Addiction 2002; 97: 1123–35.
- 48 Lynskey M. T., Heath A. C., Nelson E. C., Bucholz K. K., Madden P. A., Slutske W. S. et al. Genetic and environmental contributions to cannabis dependence in a national young adult twin sample. Psychol Med 2002; 32: 195–207.
- 49 King S. M., Iacono W. G., McGue M. Childhood externalizing and internalizing psychopathology in the prediction of early substance use. Addiction 2004; 99: 1548–59.
- 50 Macleod J., Hickman M. Commentary: understanding pathways to cannabis use and from use to harm. Int J Epidemiol 2006; 35: 680–2.
- 51 Reilly D., Didcott P., Swift W., Hall W. Long-term cannabis use: characteristics of users in an Australian rural area. Addiction 1998; 93: 837–46.
- 52 Nicholson T., White J., Duncan D. F. A survey of adult recreational drug users via the World Wide Web: the DRUGNET Study. J Psychoact Drugs 1999; 31: 415–22.
- 53 Walden N., Earleywine M. How high: quantity as a predictor of cannabis-related problems. Harm Reduct J 2008; 5: 20.
- 54 Copeland J., Swift W., Rees V. Clinical profile of participants in a brief intervention program for cannabis use disorder. J Subst Abuse Treat 2001; 20: 45–52.
- 55 Korf D. J., Benschop A., Wouters M. Differential responses to cannabis potency: a typology of users based on self-reported consumption behaviour. Int J Drug Policy 2007; 18: 168–76.
- 56 Beck K. H., Caldeira K. M., Vincent K. B., O'Grady K. E., Wish E. D., Arria A. M. The social context of cannabis use: relationship to cannabis use disorders and depressive symptoms among college students. Addict Behav 2009; 34: 764–8.
